New statewide survey finds majority support for $8.4 billion immunology and immunotherapy research bond, giving Californians hope for new treatments & cures
An overwhelming majority of likely voters support YES on Prop 38 to advance immunology and immunotherapy research that will lead to treatments and breakthrough cures, saving more lives.”
SACRAMENTO, CA, UNITED STATES, September 16, 2026 /EINPresswire.com/ -- A newly released Public Policy Institute of California (PPIC) statewide survey* finds that 55 percent of likely voters support Proposition 38, the Immunology Medical Research & Cures Initiative, to advance life-saving medical research.— Robin Swanson, spokesperson for YES on Proposition 38
Prop 38 will provide $8.4 billion in vitally needed funding to advance breakthrough immunology medical research to help prevent and treat cancer, heart disease, Alzheimer’s and other persistent and debilitating diseases impacting nearly every California family.
The PPIC Californians and Their Government survey was conducted September 4–10, 2026, and examined voter views on the November election, legislative ballot measures, citizens’ initiatives and state and national issues.
“California voters understand the incredibly high stakes for patients and families facing devastating diseases,” said Robin Swanson, spokesperson for YES on Proposition 38. “At a time when we are seeing cuts from the federal government for critical research leading to delayed scientific and medical breakthroughs, this poll shows that an overwhelming majority of likely voters support YES on Prop 38 to advance immunology and immunotherapy research that will lead to treatments and breakthrough cures, saving more lives.”
*Source: PPIC Statewide Survey, September 2026. Survey was fielded from September 4–10, 2026 (n=1,745 adults and n=1,103 likely voters).
Robin Swanson
Swanson Communications
email us here
Visit us on social media:
LinkedIn
Instagram
Facebook
YouTube
X
Other
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
